Concord Medical Services Announces Successful Closing of the Acquisition of Ownership Interest in MD Anderson Cancer Center

 Concord Medical Services Announces Successful Closing of the Acquisition of
    Ownership Interest in MD Anderson Cancer Center Proton Therapy Center

PR Newswire

BEIJING, Jan. 4, 2013

BEIJING, Jan. 4, 2013 /PRNewswire/-- Concord Medical Services Holdings
Limited ("Concord Medical" or the "Company") (NYSE: CCM), a leading specialty
hospital management solution providerand operator of the largest network of
radiotherapy and diagnostic imaging centers in China, announced today that it
has closed the acquisition of 19.98% of indirect ownership of The University
of Texas MD Anderson Cancer Center Proton Therapy Center (MD Anderson Proton
Therapy Center).

The company announced the signing of a definite agreement in connection with
the acquisition on December 11, 2012.MD Anderson Proton Therapy Center is a
leading proton treatment center in the world.Concord Medical plans to invest
and operate two proton centers in China. The transaction will enable Concord
Medical to expand its expertise and knowledge base in preparation for the
operation of future proton centers.

After the closing, Concord Medical becomes the second largest owner of the MD
Anderson Proton Therapy Center, behind MD Anderson Cancer Center.Concord
Medical will join both the Board of Directors of the PTC-Houston Management,
LP, the general partner of the center, and the center's Advisory Committee.

"The acquisition of interest in MD Anderson Proton Therapy Center plays a key
role in accelerating Concord Medical's strategic plan to build and operate
proton centers in China," says Dr. Jianyu Yang, CCM Chairman and CEO."The
transaction solidifies CCM's position as a leading radiotherapy operator in
China.We look forward to working closely with MD Anderson Proton Therapy
Center in multiple areas."

Under the terms of the agreement, CCM paid an undisclosed amount in cash to
purchase a minority interest in the general partner and facility manager of
the MD Anderson Proton Therapy Center. CCM will be entitled to receive both
management fees and cash distribution. The net impact to CCM is expected to be
accretive to EPS in 2013.

Shearman & Sterling represented Concord Medical as its legal advisor in the
acquisition.

About Concord Medical

Concord Medical Services Holdings Limited operates the largest network of
radiotherapy and diagnostic imaging centers in China, measured by revenues and
the number of centers in operation.

As of September 30, 2012, the Company operated a network of 134 centers with
75 hospital partners that spanned 53 cities and 24 provinces and
administrative regions in China. Under long-term arrangements with top-tier
hospitals in China, Concord Medical provides radiotherapy and diagnostic
imaging equipment and manages the daily operations of these centers, which are
located on the premises of its hospital partners. The Company also provides
ongoing training to doctors and other medical professionals in its network of
centers to ensure a high level of clinical care for patients. For more
information, please see http://ir.concordmedical.com.

SOURCE Concord Medical Services Holdings Limited

Website: http://ir.concordmedical.com
Contact: Concord Medical Services, Mr. Adam J. Sun, +86-10-5957-5266,
adam.sun@concordmedical.com and Ms. Gloria Huang, +86-10-5903-6688 ext. 639,
gloria.huang@concordmedical.com or Solebury Communications, In China: Ms.
Vickie Zhao, +86-10-6563-0288 ext.801, CCM@soleburyir.com and In the United
States: Mr. Richard Zubek, +1-203-428-3230, rzubek@soleburyir.com
 
Press spacebar to pause and continue. Press esc to stop.